Rahul D. Ballal's Net Worth
$2.07 Million
Who is Rahul D. Ballal?
Rahul D. Ballal has an estimated net worth of $2.07 Million. This is based on reported shares across multiple companies, which include Enliven Therapeutics, Inc., and AGIOS PHARMACEUTICALS, INC..
SEC CIK
Rahul D. Ballal's CIK is 0001805097
Past Insider Trading and Trends
2024 was Rahul D. Ballal's most active year for acquiring shares with 13 total transactions. Rahul D. Ballal's most active month to acquire stocks was the month of March. 2024 was Rahul D. Ballal's most active year for disposing of shares, totalling 16 transactions. Rahul D. Ballal's most active month to dispose stocks was the month of March. 2024 saw Rahul D. Ballal paying a total of $1,012,365.72 for 146,783 shares, this is the most they've acquired in one year. In 2024 Rahul D. Ballal cashed out on 179,690 shares for a total of $1,947,762.31, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Enliven Therapeutics, Inc. (ELVN) Snapshot price: $21.44
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$18.22 | -$688,185.87 | 22.34K |
Scheduled
|
Apr 10 - Apr 11
| ||
Form 4
|
—
|
0
|
$15.88 | -$22,818.39 | 22.34K |
Scheduled
|
Apr 4
| ||
Form 4
|
—
|
0
|
$12.41 | -$43,224.64 | 22.34K |
Scheduled
|
Apr 1
| ||
Form 4
|
—
|
0
|
$12.34 | -$181,167.69 | 22.34K |
Scheduled
|
Mar 20
| ||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 4
| -27.23% | -32.86K |
$4.66 | -$153,132.26 | 87.83K |
Feb 22
| |||
Form 4
| -8.57% | -11.31K |
$3.91 | -$44,233.83 | 120.7K |
Jan 30
| |||
Form 4
| +2,342.66% | 131.4K |
—
|
—
| 137.01K |
Jan 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 28
| |||
Form 4
|
—
|
0
|
$14.08 | -$109,228.15 |
0
|
Scheduled
|
Dec 17
| ||
Form 4
|
—
|
0
|
$14.08 | -$21.85 |
0
|
Scheduled
|
Dec 14
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AGIOS PHARMACEUTICALS, INC. (AGIO) Snapshot price: $43.28
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +40.46% | 2.3K |
—
|
—
| 7.99K |
Aug 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
| +147.18% | 3.39K |
—
|
—
| 5.69K |
Jun 13
| |||
Form 4
|
∞
| 2.3K |
—
|
—
| 2.3K |
Aug 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||